These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Research conducted by INSERM on myoclonic encephalopathies induced by the insoluble salts of bismuth used in gastroenterology]. Olive G Therapie; 1980; 35(3):305-6. PubMed ID: 6775384 [No Abstract] [Full Text] [Related]
7. [The bismuth-encephalopathy - a new pathological syndrome (author's transl)]. Eichler I Wien Klin Wochenschr; 1979 Apr; 91(9):314-20. PubMed ID: 109997 [TBL] [Abstract][Full Text] [Related]
8. [Poisoning by bismuth salts]. Sanz Gallén P; Nogué Xarau S Med Clin (Barc); 1985 Apr; 84(13):538-41. PubMed ID: 3889518 [No Abstract] [Full Text] [Related]
9. [Bismuth encephalopathy: a reappraisal of risk factors]. Lechat P; Kisch R Gastroenterol Clin Biol; 1986; 10(8-9):562-9. PubMed ID: 3536650 [No Abstract] [Full Text] [Related]
10. [Bismuth salts used in gastro-enterology. Data from animal investigations (author's transl)]. Bouvet P Ann Pharm Fr; 1981 Feb; 38(5):447-54. PubMed ID: 7011157 [No Abstract] [Full Text] [Related]
11. Bismuth toxicity--a reassessment. Bradley B; Singleton M; Lin Wan Po A J Clin Pharm Ther; 1989 Dec; 14(6):423-41. PubMed ID: 2693474 [TBL] [Abstract][Full Text] [Related]
12. Drug-induced myoclonus: frequency, mechanisms and management. Jiménez-Jiménez FJ; Puertas I; de Toledo-Heras M CNS Drugs; 2004; 18(2):93-104. PubMed ID: 14728056 [TBL] [Abstract][Full Text] [Related]